Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic markers of recurrence risk in atypical meningioma following gross total resection

1 Jan 2023

Abstract excerpt

Abstract Background Meningiomas are the most common primary central nervous system (CNS) tumor in adults and CNS World Health Organization grade 2 (atypical) meningiomas show an intermediate risk of recurrence/progression. Molecular parameters are needed to better inform management following gross total resection (GTR). Methods We performed comprehensive genomic analysis of tumor tissue from 63 patients who...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioma Diagnosis and Treatment
Share to Meningioma and schwannoma management
Share to Neurofibromatosis and Schwannoma Cases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36845294
DOI: 10.1093/noajnl/vdad004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic markers of recurrence risk in atypical meningioma following gross total resectionPMID 36845294Read ↗

NF2 mutations are associated with resistance to radiation therapy for grade 2 and grade 3 recurrent meningiomas.Semantic proximity Read ↗

Molecular Profiling of 22 Primary Atypical Meningiomas Shows the Prognostic Significance of 18q Heterozygous Loss and CDKN2A/B Homozygous Deletion on Recurrence-Free SurvivalSemantic proximity Read ↗

DNA methylation profiling to predict recurrence risk in meningioma: development and validation of a nomogram to optimize clinical managementSemantic proximity Read ↗

Meningioma Grading beyond Histopathology: Relevance of Epigenetic and Genetic Features to Predict Clinical OutcomeSemantic proximity Read ↗

Epigenetic and genomic profiling of chordoid meningioma: implications for clinical managementSemantic proximity Read ↗

A targeted gene expression biomarker predicts clinic low-risk meningioma recurrenceSemantic proximity Read ↗

Genomic landscape of meningiomas.Semantic proximity Read ↗

Clinical potential of meningioma genomic insights: a practical review for neurosurgeons.Semantic proximity Read ↗

Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responsesSemantic proximity Read ↗

Comparative genomic analysis of driver mutations in matched primary and recurrent meningiomasSemantic proximity Read ↗

Risk Factors and Genomic Characteristics of Recurrent Meningiomas Identified Through Routine Clinical TestingSemantic proximity Read ↗

Associations of meningioma molecular subgroup and tumor recurrenceSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.